Burford Capital Limited filed a Form 8-K on November 4, 2026, furnishing a press release and detailed presentation announcing its financial results for the three and nine months ended September 30, 2026.
Robbins LLP announced on November 4, 2026, that a securities class action lawsuit has been filed on behalf of purchasers of Duolingo, Inc. (NASDAQ:DUOL) Class A common stock between May 2, 2025 and February 26, 2026, alleging the company misled investors about the quality …
BrasilAgro - Brazilian Agricultural Real Estate Company (NYSE:LND) filed a Form 6-K on November 3, 2026, reporting consolidated results for the first quarter ended September 30, 2026 (1Q27), prepared in accordance with International Financial Reporting Standards (IFRS).
Southwest Gas Holdings, Inc. filed its third-quarter 2026 earnings disclosure on November 4, 2026, reporting results for the three and nine months ended September 30, 2026, alongside updates on completed rate cases and the Great Basin 2028 expansion project.
Federated Hermes, Inc. filed Amendment No. 3 to its beneficial ownership statement with respect to common stock of EyePoint, Inc. on November 4, 2026, disclosing a position as of an event date of October 31, 2026.
W.W. Grainger, Inc. reported third-quarter 2026 financial results and raised its full-year 2026 earnings outlook in a press release filed on November 4, 2026, disclosing sales of $5.181 billion and adjusted diluted EPS of $12.54.
Labcorp filed an 8-K on November 4, 2026, announcing that Chief Financial Officer Julia Wang will participate in a fireside chat at the UBS Global Healthcare Conference on November 10, 2026, at 8:45 a.m. ET.
Medtronic plc (NYSE:MDT) and The Michael J. Fox Foundation for Parkinson's Research announced a new educational initiative on November 4, 2026, aimed at helping people with Parkinson's disease and their caregivers better understand deep brain stimulation as a treatment option.
Jones Lang LaSalle Incorporated filed an 8-K on November 4, 2026, announcing the election of Nabeel Al-Amudi and Toni Townes-Whitley as independent, non-executive members of its Board of Directors, effective December 1, 2026.
Neuronetics, Inc. filed a Form 8-K on November 4, 2026, announcing its financial results for the three and nine months ended September 30, 2026, alongside an investor presentation released the same day.